Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer

被引：0
|
作者：
R D Kim
S R Alberts
C Peña
I Genvresse
A Ajavon-Hartmann
C Xia
A Kelly
J E Grilley-Olson
机构：
[1] Moffitt Cancer Center,Department of Gastrointestinal Oncology
[2] Mayo Clinic,Department of Medical Oncology
[3] Bayer HealthCare Pharmaceuticals,Division of Hematology and Oncology
[4] Inc.,undefined
[5] Bayer AG,undefined
[6] University of North Carolina,undefined
来源：
British Journal of Cancer | 2018年 / 118卷
关键词：
copanlisib; gemcitabine; cisplatin; biliary tract cancer; phase Ib trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：462 / 470
页数：8
相关论文
共 50 条
  • [1] Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer
    Kim, R. D.
    Alberts, S. R.
    Pena, C.
    Genvresse, I.
    Ajavon-Hartmann, A.
    Xia, C.
    Kelly, A.
    Grilley-Olson, J. E.
    [J]. BRITISH JOURNAL OF CANCER, 2018, 118 (04) : 462 - 470
  • [2] A Phase I Dose-Escalation Study of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer
    Ullenhag, Gustav J.
    Rossmann, Eva
    Liljefors, Maria
    [J]. PLOS ONE, 2015, 10 (04):
  • [3] Sunitinib in combination with gemcitabine plus cisplatin for advanced non-small cell lung cancer: A phase I dose-escalation study
    Reck, Martin
    Frickhofen, Norbert
    Cedres, Susana
    Gatzemeier, Ulrich
    Heigener, David
    Fuhr, Heinz-Georg
    Thall, Aron
    Lanzalone, Silvana
    Stephenson, Patricia
    Ruiz-Garcia, Ana
    Chao, Richard
    Felip, Enriqueta
    [J]. LUNG CANCER, 2010, 70 (02) : 180 - 187
  • [4] Phase 1 dose escalation study of copanlisib (BAY 80-6946) in combination with gemcitabine or gemcitabine-cisplatin in advanced cancer patients.
    Kim, Richard D.
    Alberts, Steven R.
    Renshaw, Frank Gary
    Genvresse, Isabelle
    Reif, Stefanie
    Kaplan, Jennifer
    Grilley-Olson, Juneko E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] Vorinostat in combination with gemcitabine plus platinum in patients with advanced non-small-cell lung cancer: A phase I, dose-escalation study
    Misset, J.
    Tredaniel, J.
    Descourt, R.
    Morot-Sibilot, D.
    Zalcman, G.
    Gachard, E.
    Garcia-Vargas, J.
    Rizvi, S.
    Reiser, D.
    Roben, L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Preliminary findings of a phase I dose-escalation study of sunitinib in combination with gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC)
    Reck, M.
    Frickhofen, N.
    Gatzemeier, U.
    Fuhr, H. G.
    Lanzalone, S.
    Wang, E.
    Chao, R.
    Felip, E.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 390 - 390
  • [7] Phase II study of copanlisib in combination with gemcitabine and cisplatin in advanced cholangiocarcinoma
    Tan, Elaine
    Kim, Dae Won
    Mehta, Rutika
    Cao, Biwei
    Kim, Jongphil
    Meroni, Angel
    Centeno, Barbara
    Kim, Richard D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [8] Phase I dose-escalation study of milciclib in combination with gemcitabine in patients with refractory solid tumors
    Sandrine Aspeslagh
    Kunwar Shailubhai
    Rastilav Bahleda
    Anas Gazzah
    Andréa Varga
    Antoine Hollebecque
    Christophe Massard
    Anna Spreafico
    Michele Reni
    Jean-Charles Soria
    [J]. Cancer Chemotherapy and Pharmacology, 2017, 79 : 1257 - 1265
  • [9] Phase I dose-escalation study of milciclib in combination with gemcitabine in patients with refractory solid tumors
    Aspeslagh, Sandrine
    Shailubhai, Kunwar
    Bahleda, Rastilav
    Gazzah, Anas
    Varga, Andrea
    Hollebecque, Antoine
    Massard, Christophe
    Spreafico, Anna
    Reni, Michele
    Soria, Jean-Charles
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (06) : 1257 - 1265
  • [10] A phase I dose escalation study of sunitinib in combination with gemcitabine plus cisplatin for advanced non-small cell lung cancer (NSCLC)
    Reck, M.
    Frickhofen, N.
    Gatzemeier, U.
    Fuhr, H.
    Lanzalone, S.
    Lechuga, M. J.
    Wang, E.
    Chao, R.
    Felip, E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345